Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EUDA Health Holdings (EUDA) Accounts Payables (2021 - 2025)

EUDA Health Holdings (EUDA) has disclosed Accounts Payables for 4 consecutive years, with $25886.0 as the latest value for Q4 2024.

  • Quarterly Accounts Payables rose 1908.22% to $25886.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $25886.0 through Dec 2024, up 1908.22% year-over-year, with the annual reading at $25886.0 for FY2024, 1908.22% up from the prior year.
  • Accounts Payables for Q4 2024 was $25886.0 at EUDA Health Holdings, up from $1289.0 in the prior quarter.
  • The five-year high for Accounts Payables was $1.8 million in Q1 2023, with the low at $1289.0 in Q4 2023.
  • Average Accounts Payables over 4 years is $771774.2, with a median of $359716.0 recorded in 2021.
  • The sharpest move saw Accounts Payables plummeted 99.92% in 2023, then skyrocketed 1908.22% in 2024.
  • Over 4 years, Accounts Payables stood at $359716.0 in 2021, then soared by 354.66% to $1.6 million in 2022, then tumbled by 99.92% to $1289.0 in 2023, then surged by 1908.22% to $25886.0 in 2024.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $25886.0, $1289.0, and $1.8 million for Q4 2024, Q4 2023, and Q1 2023 respectively.